(Q35976340)

11 August 2017

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma (English)

1 reference

11 August 2017

Fisken J

1

1 reference

11 August 2017

Leonard RC

2

1 reference

11 August 2017

Stewart M

3

1 reference

11 August 2017

Beattie GJ

4

1 reference

11 August 2017

Sturgeon C

5

1 reference

11 August 2017

Aspinall L

6

1 reference

11 August 2017

Roulston JE

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 July 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

1

1 reference

11 August 2017

140-145

1 reference

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Treatment decisions in advanced ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

The CA 125 tumour-associated antigen: a review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Cytoreduction in ovarian cancer: achievability and results

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Prognostic factors in patients with stage I epithelial ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Evaluation of serum CA 125 levels in the monitoring of ovarian cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

A CA125 score as a prognostic index in patients with ovarian cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Breast cancer prognostic factors: evaluation guidelines.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Cancer treatment: deciding what we can afford

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Implications of an overview of chemotherapy in advanced ovarian carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Current concepts in cancer: ovary--treatment of stages III and IV. Choice of postoperative therapy based on prognostic factors.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Long-Term Follow-Up and Prognostic Factors in Ovarian Carcinoma: The Radiumhemmet series 1958 to 1973

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968323

Radiotherapy in epithelial ovarian cancer: analysis of prognostic factors based on long-term experience

24 September 2018

1 reference

12 December 2020

Prognosis of surgically determined complete responders in advanced ovarian cancer

1 reference

12 December 2020

Ovarian carcinoma: a multivariate analysis of prognostic factors

1 reference

12 December 2020

CA 125 for the monitoring of ovarian carcinoma during primary therapy

1 reference

12 December 2020

Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy

1 reference

12 December 2020

Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group

1 reference

12 December 2020

Early serum CA125 response and outcome in epithelial ovarian cancer

1 reference

12 December 2020

The effect of abdominal surgery on the serum concentration of the tumour-associated antigen CA 125

1 reference

12 December 2020

Impact of tumour marker measurements upon management of patients with carcinoma of the ovary

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.302

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

8318405

1 reference